Parkinson’s Patients May Benefit From Ketamine, PharmaTher Applies For FDA Fast Track
Specialty pharmaceutical company PharmaTher Holdings (OTCQB: PHRRF) has submitted a Fast Track Application to the Food and D
Gilead vs. CDC: The $1B Showdown Over HIV Drug Profits
Gilead Sciences Inc (NASDAQ: GILD) is reportedly looking to fight claims that it owes the U.S. government a share of over $1 billion in profits from its HIV-treatment drug Truvada that could help prevent the disease.
US-China Tensions Play Spoilsport For Huawei’s Malaysian Ambitions
The EU and U.S. have warned the Malaysian government against national security and foreign investment threat from awarding a 5G…
Funding the Fight: Facebook Pours Millions into American Edge Project to Combat Tech Regulation
Meta Platforms, Inc’s (NASDAQ:META) Facebook emerged as the leading donor for an advocacy group fighting antitrust legislation that would have more…
Alibaba Likely To Struggle With Cloud Growth, Analysts Say; Needs New Growth Driver For Other Businesses
U.S. and China’s geopolitical tensions wiped off significant stock price gains of Alibaba Group Holding Limited (NYSE:BABA) from recent restructuring plans.…
How Much Crypto Exchange Poloniex Had To Shell Out To U.S. Regulatory Agency For 65,942 Sanctions Violations
Cryptocurrency exchange Poloniex LLC agreed to pay a $7.6 million settlement to resolve charges of alleged sanctions violations.
What’s Going On With Roundhill Cannabis ETF Today
Listed Funds Trust Roundhill Cannabis ETF (BATS: WEED) is trading higher Monday in sympathy with reintroducing a marijuana banking bill last week.
What Is Going On With Addus HomeCare Stock Today
Addus HomeCare Corp (NASDAQ: ADUS) shares had plunged over 28% last Friday after it expressed its view against specific clauses of the Biden Administration's proposed rule Department of Health and Human Services (HHS), known as "Assuring Access to Medicaid Services.
After Visa, DOJ Probes Mastercard Over Alleged Anti-Competitive Debit-Card Practices
The U.S. Department of Justice is investigating Mastercard Inc (NYSE:MA) regarding the potential violation of antitrust rules in its debit-card business.…